1219503-87-3 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 2-(2,4-difluorophenyl)nicotinate is used as an intermediate in the synthesis of various pharmaceutical products. Its unique structure and properties make it a valuable building block for the development of new drug candidates.
Used in Anti-inflammatory and Analgesic Applications:
Ethyl 2-(2,4-difluorophenyl)nicotinate has been studied for its potential as an anti-inflammatory and analgesic agent. Its specific chemical structure may contribute to its ability to modulate inflammatory pathways and provide pain relief, making it a promising candidate for the treatment of various inflammatory and painful conditions.
Used in Drug Synthesis for Disease Treatment:
Ethyl 2-(2,4-difluorophenyl)nicotinate has shown potential as a building block for the synthesis of drug candidates for the treatment of various diseases. Its unique structure and properties may enable the development of novel therapeutic agents with improved efficacy and selectivity for specific disease targets.
Check Digit Verification of cas no
The CAS Registry Mumber 1219503-87-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,9,5,0 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1219503-87:
(9*1)+(8*2)+(7*1)+(6*9)+(5*5)+(4*0)+(3*3)+(2*8)+(1*7)=143
143 % 10 = 3
So 1219503-87-3 is a valid CAS Registry Number.
1219503-87-3Relevant academic research and scientific papers
SOLID FORMS OF 2-(2, 4-DIFLUOROPHENYL)-6-(1-(2,6-DIFLUOROPHENYL)UREIDO)NICOTINAMIDE
-
Page/Page column 45, (2010/09/03)
This invention relates to solid forms of 2-(2, 4-difluorophenyl)-6-(l- (2,6-difluorophenyl)ureido)nicotinamide and pharmaceutical compositions thereof, and methods and uses therewith.
PROCESSES FOR PRODUCING PHENYL-6-(1-(PHENYL)UREIDO)NICOTINAMIDES)
-
Page/Page column 22-23, (2010/09/03)
The present invention relates to processes for the preparation of compounds useful as inhibitors of p38 kinase. The processes of the present invention are amenable for large scale preparation and produce stable phenyl-6-(l-(phenyl)ureido)nicotinamides in
